DrugDashboards

Oxymorphone Hydrochloride

Oxymorphone Hydrochloride · OXYMORPHONE HYDROCHLORIDE 5 mg/1 · Tablet · Oral · KVK-Tech, Inc.

NDC 10702-0070-01 · 100 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 14% over the past year, to $0.5201 per unit. One of its named manufacturing plants, Kvk-Tech, Inc., failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 10702-0070-06) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$1.62per unit
middle half $0.8183–$1.79 · 220 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $1.62
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
4%of plans cover it
tier 4 · prior auth 0% · step therapy 0% · qty limit 87%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

$0$1.00$2.00$3.00Nov 2013Apr 2023$0.5201
89 price points · per · last surveyed Invalid Date · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Medicaid spend (2023)

$6,246
92 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
ANDA203601
TE code
AB
Approval date
Jan 30, 2013
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Oxymorphone Hydrochloride (Tablet)

LabelerStrengthFirst seenLast seen
Aurolife Pharma, LLCOXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Aurolife Pharma, LLCOXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackOXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, IncOXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, IncOXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Epic Pharma, LLCOXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Epic Pharma, LLCOXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.OXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.OXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
KVK-Tech, Inc.OXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
KVK-Tech, Inc.OXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 7.5 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 40 mg/1Jul 15, 2026Sep 2, 2026
Patheon Manufacturing Services LLCOXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
XLCare Pharmaceuticals, Inc.OXYMORPHONE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
XLCare Pharmaceuticals, Inc.OXYMORPHONE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Oxymorphone Hydrochloride — NDC 10702-0070-01," retrieved September 3, 2026, https://drugdashboards.com/drug/10702007001.

Free to cite with attribution — see how the data is put together.